Formulation and Evaluation of Iornoxicam as Dissolving Microneedle Patch

The objective of the study was to develop microneedle (MN) patch, with suitable properties to ensure the delivery of a therapeutic level of lornoxicam (LXM) in a period suitable to replace parenteral administration in patients, especially those who fear needles. The used polymers were cold water-sol...

Full description

Saved in:
Bibliographic Details
Main Authors: Adeeb R. Alkhiro (Author), Mowafaq M. Ghareeb (Author)
Format: Book
Published: College of Pharmacy University of Baghdad, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6808bd87c88a4e9c82ffe50f5d7ea8c0
042 |a dc 
100 1 0 |a Adeeb R. Alkhiro  |e author 
700 1 0 |a Mowafaq M. Ghareeb  |e author 
245 0 0 |a Formulation and Evaluation of Iornoxicam as Dissolving Microneedle Patch 
260 |b College of Pharmacy University of Baghdad,   |c 2020-06-01T00:00:00Z. 
500 |a 10.31351/vol29iss1pp184-194 
500 |a 2521-3512 
500 |a 1683-3597 
520 |a The objective of the study was to develop microneedle (MN) patch, with suitable properties to ensure the delivery of a therapeutic level of lornoxicam (LXM) in a period suitable to replace parenteral administration in patients, especially those who fear needles. The used polymers were cold water-soluble polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP) of low molecular weight with PEG 400 as plasticizer and Tween 80 (to enhance the release) using micro molding technique. Patches were studied for needle morphology, drug content, axial fracture force measurement and drug release while the optimized formulas were further subjected to pH measurement, folding endurance, ex vivo permeation study, histopathology study, stability study and compatibility study. The patch with 11:1 ratio of PVA to PVP, 30% solid content, 5% PEG 400 and 3% Tween 80 resulted in axial needle fracture force value of (1.35 N) which is suitable for skin penetration. The release was fast with almost 100% of drug released in 60 minutes. The permeation was enhanced significantly with a steady state flux of about 3.1 times that of the solution. The lag time of MN is shorter in comparison with ordinary patch. Histopathology studies demonstrated the safety of the formulation, both stability studies and compatibility studies showed the suitability of the formulation. The results indicated that LXM microneedle patch could enhance drug permeation while achieving fast and painless administration. Keywords: Microneedle patch, Polyvinyl alcohol, Polyvinylpyrrolidone, Fracture force, Lornoxicam. 
546 |a EN 
690 |a Microneedle patch, polyvinyl alcohol, polyvinylpyrrolidone, Fracture force, Lornoxicam 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Iraqi Journal of Pharmaceutical Sciences, Vol 29, Iss 1 (2020) 
787 0 |n https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/985 
787 0 |n https://doaj.org/toc/2521-3512 
787 0 |n https://doaj.org/toc/1683-3597 
856 4 1 |u https://doaj.org/article/6808bd87c88a4e9c82ffe50f5d7ea8c0  |z Connect to this object online.